| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.44 | 0.1 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.17 | 0.03 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.05 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0008 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.12 | 0.05 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |